Abstract:
Provided herein are pyrrolomycin derivatives, which can be used to modulate Mcl-1, inhibit proliferation of bacteria and pathogens, as well as to treat infectious diseases and cancers.
Abstract:
The present disclosure discloses compounds capable of modulating the activity of α-amino-β-carboxymuconic acid semialdehyde decarboxylase (ACMSD), which are useful for the prevention and/or the treatment of diseases and disorders associated with defects in NAD + biosynthesis, e.g. , metabolic disorders, neurodegenerative diseases, chronic inflammatory diseases, kidney diseases, and diseases associated with ageing. The present application also discloses pharmaceutical compositions comprising said compounds and the use of such compounds as a medicament.
Abstract:
The present invention relates to fungicidal imidazolyl and triazolyl compounds (I), agrochemical compositions comprising them, to their use and to methods for combating phytopathogenic fungi. The present invention also relates to seeds treated with at least one such compound. Furthermore the invention relates to processes for preparing compounds of formula I as well as to specific intermediates that are obtained during the reaction sequence.
Abstract:
The present invention relates to fungicidal imidazolyland triazolyl compounds (I), agrochemical compositions comprising them, to their use and to methods for combating phytopathogenic fungi. The present invention also relatesto seeds treated with at least one such compound. Furthermore the invention relates to processes for preparing compounds of formula (I) as well asto specific intermediates that are obtained during the reaction sequence.
Abstract:
The invention provides processes for preparing intermediates useful for preparing compounds of the formula (IV), or a salt thereof, where R 1-3 are as defined in the specification.
Abstract:
Disclosed are compounds of Formula (1), including all geometric and stereoisomers, N -oxides, and salts thereof, wherein J is Q 2 or R 1 ; X is N, CR 2 or CQ 3 ; Y is N or CR 3 ; Z is N or CR 4 ; and Q 1 , Q 2 , Q 3 , R 1 R 2 and R 3 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula (1) and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.
Abstract:
This invention relates to compounds and methods for the inhibition of sirtuin enzymatic activity. More particularly, the invention provides for compounds of formula (I), Y __ L __ Z __ D, and N-oxides, hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes thereof, and racemic and scalemic mixtures, diastereomers and enantiomers thereof, wherein Y, L, Z and D are as defined in the specification.
Abstract:
The present invention relates to di(hetero)arylcyclohexane derivatives of the formula (I), in which Ar 1 , Ar 2 , R 1 and R 2 have the meanings indicated in the claims. The compounds of the formula (I) are valuable pharmaceutical active compounds which inhibit ATP-sensitive potassium channels in the heart muscle and are suitable, for example, for the treatment of disorders of the cardiovascular system such as arrhythmias or a decreased contractility of the heart, such as can occur, for example, in coronary heart disease, cardiac insufficiency or cardiomyopathies. In particular, they are suitable for the prevention of sudden cardiac death. The invention furthermore relates to processes and intermediates for the preparation of the compounds of the formula (I), their use and pharmaceutical compositions comprising them.